EGFR and neoplasm: Moreover, univariate analysis of patients with EGFR mutations in ctDNA identified the L858R mutation in tumor tissue or in ctDNA as a marker of shorter OS (hazard ratio, 2.70, P < 0.001) and PFS (hazard ratio, 2.04, P = 0.008).